The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma

International Journal of Oncology

Volumn 32, Issue 1, 2008, Pages 145-151

  Miyazaki, Yasuo ^a   Hara, Akira ^a   Kato, Keizo ^a   Oyama, Takeru ^a   Yamada, Yasuhiro ^a   Mori, Hideki ^a   Shibata, Toshiyuki ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

HIF 1 ; Hypoxia; Matrix metalloproteinase; Oral squamous cell carcinoma; Pimonidazole

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROENVIRONMENT; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; STROMA; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 38749122031     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.1.145     Document Type: Article

References (21)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
2. Myoung H, Kim MJ, Hong SD, Lee JI, Lim CY and Hong SP: Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma. Cancer Lett 185: 201-209, 2002.
3. Kato K, Hara A, Kuno T, Mori H, Yamashita T, Tolda M and Shibata T: Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol 132: 735-743, 2006.
4. Quintero M, Mackenzie N and Brennan PA: Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur J Surg Oncol 30: 465-468, 2004.
5. Semenza GL: HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107: 1-3, 2001.
6. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
7. Sasabe E, Tatemoto Y, Li D, Yamamoto T and Osaki T: Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 96: 394-402, 2005.
8. Gu J, Milligan J and Huang LE: Molecular mechanism of hypoxia-inducible factor 1alpha-p300 interaction. A leucine-rich interface regulated by a single cysteine. J Biol Chem 276: 3550-3554, 2001.
9. Rijken PF, Bernsen HJ, Peters JP, Hodgkiss RJ, Raleigh JA and van der Kogel AJ: Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 48: 571-582, 2000.
10. Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, De Wilde PC, Bussink J, Raleigh JA and van der Kogel AJ: Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62: 7066-7074, 2002.
11. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
12. Miyoshi A, Kitajima Y, Ide T, Ohtaka K, Nagasawa H, Uto Y, Hori H and Miyazaki K: Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1-alpha-independent manner. Int J Oncol 29: 1533-1539, 2006.
13. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13: 167-171, 2001.
14. Bussink J, Kaanders JH and van der Kogel AJ: Tumor hypoxia at the micro-regional level: clinical relevante and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67: 3-15, 2003.
15. Arteel GE, Thurman RG, Yates JM and Raleigh JA: Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72: 889-895, 1995.
16. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
17. Munoz-Najar UM, Neurath KM, Vumbaca F and Claffey KP: Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25: 2379-2392, 2006.
18. Semenza GL: Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7: 345-350, 2001.
19. Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S and Ohnishi T: Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30: 793-802, 2007.
20. Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H, Toida M and Shibata T: Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 131: 340-346, 2005.
21. Thomas GT, Lewis MP and Speight PM: Matrix metalloproteinases and oral cancer. Oral Oncol 35: 227-233, 1999.